Callyspongiolide kills cells by inducing mitochondrial dysfunction via cellular iron depletion

Area of Science:

• Marine Natural Products Chemistry
• Cancer Therapeutics
• Cellular Biology

Background:

• Callyspongiolide is a potent marine natural product with potential as an antibody-drug conjugate warhead.
• The precise mechanism of callyspongiolide's cytotoxicity is currently unknown.
• Understanding its action is crucial for developing targeted cancer therapies.

Purpose of the Study:

• To elucidate the mechanism of action and cytotoxicity of callyspongiolide.
• To identify direct protein targets or cellular pathways affected by callyspongiolide.
• To explore the potential of callyspongiolide in cancer treatment.

Main Methods:

• Label-free target identification using thermal stability-shift-based fluorescence difference in 2-D gel electrophoresis (TS-FITGE).
• Molecular biology techniques to assess mitochondrial and lysosomal function.
• Autophagy inhibition assays.
• Iron depletion and supplementation studies.

Main Results:

• Callyspongiolide treatment induced a unique protein separation phenomenon on 2-D gels via TS-FITGE.
• The compound caused mitochondrial and lysosomal dysfunction, alongside autophagy inhibition.
• Lysosomal dysfunction led to cellular iron depletion, subsequently causing mitochondrial dysfunction and cytotoxicity.
• Cytotoxic effects were reversible with iron supplementation.

Conclusions:

• Callyspongiolide induces cytotoxicity through lysosomal deacidification, leading to iron depletion and mitochondrial dysfunction.
• This mechanism operates independently of known programmed cell death pathways.
• TS-FITGE provided unique insights into callyspongiolide's action, despite not identifying direct protein targets.